WWW.JNEUROSCI.ORG
-
Life science instruments for behavioral neuroscience research
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, May 18, 2005, 25(20):5051-5060; doi:10.1523/JNEUROSCI.0128-05.2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schenzer, A.
Right arrow Articles by Schwake, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schenzer, A.
Right arrow Articles by Schwake, M.

 Previous Article  |  Next Article 

Cellular/Molecular
Molecular Determinants of KCNQ (Kv7) K+ Channel Sensitivity to the Anticonvulsant Retigabine

Anne Schenzer,1 * Thomas Friedrich,2 * Michael Pusch,3 Paul Saftig,1 Thomas J. Jentsch,4 Joachim Grötzinger,1 and Michael Schwake1

1Institute of Biochemistry, Christian-Albrechts-University Kiel, D-24098 Kiel, Germany, 2Max-Planck-Institute of Biophysics, D-60438 Frankfurt/Main, Germany, 3Istituto di Biofisica, I-16149 Genova, Italy, and 4Zentrum für Molekulare Neurobiologie Hamburg, D-20251 Hamburg, Germany

Epilepsy is caused by an electrical hyperexcitability in the CNS. Because K+ channels are critical for establishing and stabilizing the resting potential of neurons, a loss of K+ channels could support neuronal hyperexcitability. Indeed, benign familial neonatal convulsions, an autosomal dominant epilepsy of infancy, is caused by mutations in KCNQ2 or KCNQ3 K+ channel genes. Because these channels contribute to the native muscarinic-sensitive K+ current (M current) that regulates excitability of numerous types of neurons, KCNQ (Kv7) channel activators would be effective in epilepsy treatment. A compound exhibiting anticonvulsant activity in animal seizure models is retigabine. It specifically acts on the neuronally expressed KCNQ2-KCNQ5 (Kv7.2-Kv7.5) channels, whereas KCNQ1 (Kv7.1) is not affected. Using the differential sensitivity of KCNQ3 and KCNQ1 to retigabine, we constructed chimeras to identify minimal segments required for sensitivity to the drug. We identified a single tryptophan residue within the S5 segment of KCNQ3 and also KCNQ2, KCNQ4, and KCNQ5 as crucial for the effect of retigabine. Furthermore, heteromeric KCNQ channels comprising KCNQ2 and KCNQ1 transmembrane domains (attributable to transfer of assembly properties from KCNQ3 to KCNQ1) are retigabine insensitive. Transfer of the tryptophan into the KCNQ1 scaffold resulted in retigabine-sensitive heteromers, suggesting that the tryptophan is necessary in all KCNQ subunits forming a functional tetramer to confer drug sensitivity.

Key words: epilepsy; KCNQ; M current; potassium channels; retigabine; excitability


Received Jan 19, 2005; revised April 15, 2005; accepted April 15, 2005.




This article has been cited by other articles:


Home page
JGPHome page
C. C. Hernandez, B. Falkenburger, and M. S. Shapiro
Affinity for phosphatidylinositol 4,5-bisphosphate determines muscarinic agonist sensitivity of Kv7 K+ channels
J. Gen. Physiol., November 11, 2009; 134(5): 437 - 448.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. I. Brueggemann, A. R. Mackie, B. K. Mani, L. L. Cribbs, and K. L. Byron
Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Vascular Smooth Muscle Ion Channels May Account for Differences in Cardiovascular Risk Profiles
Mol. Pharmacol., November 1, 2009; 76(5): 1053 - 1061.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. A. Jepps, I. A. Greenwood, J. D. Moffatt, K. M. Sanders, and S. Ohya
Molecular and functional characterization of Kv7 K+ channel in murine gastrointestinal smooth muscles
Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G107 - G115.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. Lange, J. Geissendorfer, A. Schenzer, J. Grotzinger, G. Seebohm, T. Friedrich, and M. Schwake
Refinement of the Binding Site and Mode of Action of the Anticonvulsant Retigabine on KCNQ K+ Channels
Mol. Pharmacol., February 1, 2009; 75(2): 272 - 280.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. R. Mackie and K. L. Byron
Cardiovascular KCNQ (Kv7) Potassium Channels: Physiological Regulators and New Targets for Therapeutic Intervention
Mol. Pharmacol., November 1, 2008; 74(5): 1171 - 1179.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Gao, Q. Xiong, H. Sun, and M. Li
Desensitization of Chemical Activation by Auxiliary Subunits: CONVERGENCE OF MOLECULAR DETERMINANTS CRITICAL FOR AUGMENTING KCNQ1 POTASSIUM CHANNELS
J. Biol. Chem., August 15, 2008; 283(33): 22649 - 22658.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Maljevic, T. V. Wuttke, and H. Lerche
Nervous system KV7 disorders: breakdown of a subthreshold brake
J. Physiol., April 1, 2008; 586(7): 1791 - 1801.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. D. Wickenden, J. L. Krajewski, B. London, P. K. Wagoner, W. A. Wilson, S. Clark, R. Roeloffs, G. McNaughton-Smith, and G. C. Rigdon
N-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): A Novel, Selective KCNQ2/Q3 Potassium Channel Activator
Mol. Pharmacol., March 1, 2008; 73(3): 977 - 986.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Q. Xiong, H. Sun, Y. Zhang, F. Nan, and M. Li
Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openers
PNAS, February 26, 2008; 105(8): 3128 - 3133.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. V. Wuttke, K. Jurkat-Rott, W. Paulus, M. Garncarek, F. Lehmann-Horn, and H. Lerche
Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations
Neurology, November 27, 2007; 69(22): 2045 - 2053.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Perry, F. B. Sachse, and M. C. Sanguinetti
Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator
PNAS, August 21, 2007; 104(34): 13827 - 13832.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. V. Soldovieri, M. R. Cilio, F. Miceli, G. Bellini, E. Miraglia del Giudice, P. Castaldo, C. C. Hernandez, M. S. Shapiro, A. Pascotto, L. Annunziato, et al.
Atypical Gating Of M-Type Potassium Channels Conferred by Mutations in Uncharged Residues in the S4 Region of KCNQ2 Causing Benign Familial Neonatal Convulsions
J. Neurosci., May 2, 2007; 27(18): 4919 - 4928.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. Peretz, A. Sheinin, C. Yue, N. Degani-Katzav, G. Gibor, R. Nachman, A. Gopin, E. Tam, D. Shabat, Y. Yaari, et al.
Pre- and Postsynaptic Activation of M-Channels By a Novel Opener Dampens Neuronal Firing and Transmitter Release
J Neurophysiol, January 1, 2007; 97(1): 283 - 295.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Schwake, D. Athanasiadu, C. Beimgraben, J. Blanz, C. Beck, T. J. Jentsch, P. Saftig, and T. Friedrich
Structural determinants of M-type KCNQ (Kv7) K+ channel assembly.
J. Neurosci., April 5, 2006; 26(14): 3757 - 3766.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-